Worldwide Short-Acting Beta-Agonists Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355279
- 124 Pages
- March 2021
- Healthcare
Short-acting beta-agonists (bronchodilators) are the drugs made use of to deal with respiratory illness, mostly made use of for treating asthma. short-acting beta-agonists are called a quick-acting and also relieving drug from bronchial asthma attacks, as it aids to rapidly open up the air passages.
It likewise provides immediate alleviation to take care of both acute and also steady exacerbations of chronic obstructive lung illness. one of the most typically prescribed medicine is salbutamol in the short-acting beta-agonists market.
The short-acting beta-agonists market is most likely to grow with the boosting number of individuals experiencing bronchial asthma as well as chronic obstructive pulmonary disease.
Pandemic coronavirus is disrupting all the sectors. the novel coronavirus is establishing various possibilities in the short-acting beta-agonists market. people having any type of type of pulmonary conditions are most likely to obtain coronavirus disease.
Given that a significant number of population is dealing with asthma as well as persistent obstructive pulmonary disease around the world, it has actually resulted in a rise in the need to take care of asthma as well as persistent obstructive lung disease which subsequently is driving the growth of the short-acting beta-agonists market.
Short-acting beta-agonists market: vehicle drivers as well as restraints-
Increasing occurrence of asthma and chronic illness such as persistent obstructive pulmonary illness are driving the development of the short-acting beta-agonists market.
The appearance of numerous medicines to treat severe bronchial asthma and also novel combination therapies are anticipated to rise the growth of the short-acting beta-agonists market.
In addition, improvements in the technologies and also item technology are bring about boosted need for short-acting beta-agonists. nevertheless, the exclusivity of top quality medications as well as expiration of licenses are limiting the development of the short-acting beta-agonists market.
Short-acting beta-agonists market: overview
Based on the dosage kind, solution and injectable are the most widely made use of dosage form in the short-acting beta-agonists market. based upon the application, short-acting beta-agonists are generally utilized in the treatment of bronchial asthma as a result of the increasing demand to take care of extreme asthma attacks.
Based upon the circulation network, hospital drug stores are one of the most successful segment in the short-acting beta-agonists market.
Short-acting beta-agonists are the option of medication in the marketplace for treating bronchial asthma. they typically show their result within a couple of mins to deal with the symptoms such as wheezing, breast rigidity, and also shortness of breathing.
Typically recommended short-acting beta-agonists are albuterol, pirbuterol, levalbuterol. apart from this, short-acting beta-agonists have numerous adverse effects such as headaches, unexpectedly noticeable heart beats, trembling in the hands, muscle mass pains, as well as others.
Scientists are constantly working to decrease the adverse effects of short-acting beta-agonists in dealing with bronchial asthma.
Short-acting beta-agonists market: region-wise expectation
The United States and Canada as well as Europe are expected to dominate the global short-acting beta-agonists market, owing to the higher fostering of medicines and also innovation in medication discovery in the regions.
Likewise, high prevalence rate of bronchial asthma and persistent obstructive lung illness are expected to boost the growth of the short-acting beta-agonists market in these areas.
Boost in health care expense in the creating area like Asia-pacific is expected to push the international short-acting beta-agonists market development over the projection period.
Likewise, increasing population in countries like India as well as China is expected to more drive the growth of the marketplace in these areas. in center east and Africa, the short-acting beta-agonist market is estimated to broaden due to increasing asthma people as well as raising air contamination.
Short-acting beta-agonists market: key market participants
Several of the market participants in the global short-acting beta-agonists market identified across the value chain include:
Bayer ag
Teva drugs industries ltd.
F. hoffmann-la roche ag
Mylan n.v.
Glaxosmithkline plc.
Cipla minimal
Glaxosmithkline plc.
Merck & co.
Schering-plough firm
Johnson & johnson
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Short-Acting Beta-Agonists by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Short-Acting Beta-Agonists Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Short-Acting Beta-Agonists Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Short-Acting Beta-Agonists Production from 2014-2020
4.3.1.2 North America Short-Acting Beta-Agonists Consumption from 2014-2020
4.3.1.3 North America Short-Acting Beta-Agonists Import and Export from 2014-2020
4.3.1.4 North America Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Short-Acting Beta-Agonists Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Short-Acting Beta-Agonists Production from 2014-2020
4.3.2.2 Europe Short-Acting Beta-Agonists Consumption from 2014-2020
4.3.2.3 Europe Short-Acting Beta-Agonists Import and Export from 2014-2020
4.3.2.4 Europe Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Short-Acting Beta-Agonists Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Short-Acting Beta-Agonists Production from 2014-2020
4.3.3.2 Asia-Pacific Short-Acting Beta-Agonists Consumption from 2014-2020
4.3.3.3 Asia-Pacific Short-Acting Beta-Agonists Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Short-Acting Beta-Agonists Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Short-Acting Beta-Agonists Production from 2014-2020
4.3.4.2 Latin America Short-Acting Beta-Agonists Consumption from 2014-2020
4.3.4.3 Latin America Short-Acting Beta-Agonists Import and Export from 2014-2020
4.3.4.4 Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Short-Acting Beta-Agonists Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Short-Acting Beta-Agonists Production from 2014-2020
4.3.5.2 Middle East & Africa Short-Acting Beta-Agonists Consumption from 2014-2020
4.3.5.3 Middle East & Africa Short-Acting Beta-Agonists Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Short-Acting Beta-Agonists Market from 2020-2026
7.1 Future Forecast of Global Short-Acting Beta-Agonists Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Short-Acting Beta-Agonists Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Short-Acting Beta-Agonists Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
800 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Short-Acting Beta-Agonists Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Short-Acting Beta-Agonists Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Short-Acting Beta-Agonists
Figure Type 2 of Short-Acting Beta-Agonists
Figure Type 3 of Short-Acting Beta-Agonists
Table Global Short-Acting Beta-Agonists Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Short-Acting Beta-Agonists Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Short-Acting Beta-Agonists
Figure Application 2 of Short-Acting Beta-Agonists
Figure Application 3 of Short-Acting Beta-Agonists
Table Global Short-Acting Beta-Agonists Production Value ($) by Regions
Table Global Short-Acting Beta-Agonists Production Value Share by Regions
Table Global Short-Acting Beta-Agonists Production by Regions
Table Global Short-Acting Beta-Agonists Production Share by Regions
Table Global Short-Acting Beta-Agonists Consumption by Regions
Table Global Short-Acting Beta-Agonists Consumption Share by Regions
Figure North America Short-Acting Beta-Agonists Production and Growth Rate from 2014-2020
Figure North America Short-Acting Beta-Agonists Consumption and Growth Rate from 2014-2020
Table North America Short-Acting Beta-Agonists Import and Export from 2014-2020
Table North America Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
Table North America Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
Table North America Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
Figure Europe Short-Acting Beta-Agonists Production and Growth Rate from 2014-2020
Figure Europe Short-Acting Beta-Agonists Consumption and Growth Rate from 2014-2020
Table Europe Short-Acting Beta-Agonists Import and Export from 2014-2020
Table Europe Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
Table Europe Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
Table Europe Short-Acting Beta-Agonists Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Short-Acting Beta-Agonists Production and Growth Rate from 2014-2020
Figure Asia-Pacific Short-Acting Beta-Agonists Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Short-Acting Beta-Agonists Import and Export from 2014-2020
Table Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
Figure Latin America Short-Acting Beta-Agonists Production and Growth Rate from 2014-2020
Figure Latin America Short-Acting Beta-Agonists Consumption and Growth Rate from 2014-2020
Table Latin America Short-Acting Beta-Agonists Import and Export from 2014-2020
Table Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Short-Acting Beta-Agonists Production and Growth Rate from 2014-2020
Figure Middle East & Africa Short-Acting Beta-Agonists Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Short-Acting Beta-Agonists Import and Export from 2014-2020
Table Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Short-Acting Beta-Agonists Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Short-Acting Beta-Agonists Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Short-Acting Beta-Agonists Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Short-Acting Beta-Agonists Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Short-Acting Beta-Agonists Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Short-Acting Beta-Agonists Production and Growth Rate Forecast by Types (2020-2026)
Table Global Short-Acting Beta-Agonists Consumption and Growth Rate Forecast by End-User/Applications (2020-2817)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
